Biopharmaceuticals
Kristin Bullok, PhD
Global Patient Safety, Benefit-Risk Scientist
Eli Lilly and Company
Brett Hauber, PhD
Senior Director, Patient Preference Elicitation
Pfizer, Inc.
Sara Eggers, PhD
Staff Director
U.S. Food and Drug Administration
Francesco Pignatti
Head of Oncology, Haematology, Diagnostics-Safety and Efficacy Sector
European Medicines Agency
Kim Quaintance-Lunn
VP, US Regulatory Lead
Bayer